Trial intelligence / Profile preview

GASTRIM: Gastric Emptying in STEMI

NCT02251249Phase 4Terminated

Sponsor
Centre Hospitalier Universitaire de Bordeaux
Start
Dec 2014
Primary completion
Sep 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of prasugrel, ticagrelor in ST elevation myocardial infarction (STEMI), sponsored by Centre Hospitalier Universitaire de Bordeaux. Started Dec 2014; status: terminated.

02

Drugs

prasugrelticagrelor
03

Conditions

ST elevation myocardial infarction (STEMI)

Beyond the preview

Go deeper on NCT02251249.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02251249.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call